Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy
Journal of Gastroenterology · 2025
DOI: 10.1007/s00535-024-02174-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Takao Watanabe und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Antiviral Agents, Liver Cirrhosis, Hepatitis C, Chronic. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The clinical course of esophagogastric varices (EGV) after sustained virological response (SVR) with direct-acting antiviral (DAA) therapy has not been clearly elucidated. The predictors for the worsening/improvement of EGV after SVR with DAA therapy were investigated. METHODS: Of the cirrhosis patients who achieved SVR with DAA therapy, 328 patients who underwent endoscopic examinations both before and after DAA therapy were enrolled. The predictors of EGV worsening or improvement were investigated. RESULTS: Multivariate analysis identified a history of ascites retention, albumin at baseline, and MELD score at baseline as independent factors that contributed to EGV exacerbation. On multivariate analysis, two factors, BMI and platelet count, were related to EGV improvement. An integrated scoring system was created using these risk factors with or without weighting according to each hazard ratio, and the patients were divided into three groups. A scoring system with weighting of each factor appeared to be more useful, with fewer intermediate patients and more cases classified into the low-risk and high-risk groups. CONCLUSION: Esophagogastric varices after SVR have a varied clinical course. Using this scoring system that can accurately predict EGV outcomes in clinical settings, it may be feasible to establish a risk-based EGV surveillance plan following SVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
- Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan. tokumoto.yoshio.cc@ehime-u.ac.jp.
- Center for Liver-Biliary-Pancreatic Diseases, Matsuyama Red Cross Hospital, 1 Bunkyocho, Matsuyama, Ehime, 790-8524, Japan.
- Department of Gastroenterology, Ehime Prefectural Central Hospital, 83 Kasugamachi, Matsuyama, Ehime, 790-0024, Japan.
- Department of Gastroenterology, Matsuyama Shimin Hospital, 2-6-5 Ootemachi, Matsuyama, Ehime, 790-0067, Japan.
- Department of Gastroenterology, Saiseikai Imabari Hospital, 7-1-6 Kitamura, Imabari, Ehime, 799-1502, Japan.
ORCID-Profile: Yoshio Tokumoto
Zitieren
APA
Watanabe, T., Tokumoto, Y., Ochi, H., Mashiba, T., Tada, F., Hiraoka, A., Kisaka, Y., Tanaka, Y., Yagi, S., Nakanishi, S., Sunago, K., Yamauchi, K., Higashino, M., Hirooka, K., Tange, M., Yukimoto, A., Morita, M., Okazaki, Y., Hirooka, M., …, & Hiasa, Y. (2025). Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02174-z
Vancouver
Watanabe T, Tokumoto Y, Ochi H, Mashiba T, Tada F, Hiraoka A, et al. Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy. Journal of Gastroenterology. 2025. doi:10.1007/s00535-024-02174-z
BibTeX
@article{Watanabe2025,
author = {Watanabe, Takao and Tokumoto, Yoshio and Ochi, Hironori and Mashiba, Toshie and Tada, Fujimasa and Hiraoka, Atsushi and Kisaka, Yoshiyasu and Tanaka, Yoshinori and Yagi, Sen and Nakanishi, Seiji and Sunago, Kotaro and Yamauchi, Kazuhiko and Higashino, Makoto and Hirooka, Kana and Tange, Masaaki and Yukimoto, Atsushi and Morita, Makoto and Okazaki, Yuki and Hirooka, Masashi and Abe, Masanori and Hiasa, Yoichi},
title = {Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy},
journal = {Journal of Gastroenterology},
year = {2025},
doi = {10.1007/s00535-024-02174-z}
}
EUVIMED